Hypromellose 2208 (4000 MPa.s)
Medically reviewed by Drugs.com. Last updated on Apr 16, 2024.
Excipient (pharmacologically inactive substance)
What is it?
Hypromellose, also commonly known as hydroxypropyl methycellulose (HPMC) is a coating agent and film-former used as an inactive ingredient in the pharmaceutical industry.[1] It has also been used as a rate-controlling polymer for sustained-release dose forms.
As a powder, hypromellose is off-white to beige and may be in granules. Hypromellose is considered an inert ingredient. It has a high viscosity and is often used in ophthalmic preparations as artificial tears for dry eyes.[2] In the US, it is available over-the-counter (OTC) in such products as Isopto Tears and Nature’s Tears.
Some examples of medications containing Hypromellose 2208 (4000 MPa.s)
- Alprazolam Extended Release 3 mg
- Alprazolam Extended Release 0.5 mg
- Alprazolam Extended Release 2 mg
- Alprazolam Extended Release 1 mg
- Belviq XR 20 mg
- Carbidopa and Levodopa Extended-Release 25 mg / 100 mg
- Cenestin synthetic conjugated estrogens, A 0.45 mg
- Donepezil Hydrochloride 23 mg
- Mesalamine Extended-Release 375 mg
- Nifedipine Extended-Release 60 mg
- Nifedipine Extended-Release 30 mg
- Nifedipine Extended-Release 90 mg
- Quetiapine Fumarate Extended-Release 50 mg
- Quetiapine Fumarate Extended-Release 300 mg
- Quetiapine Fumarate Extended-Release 150 mg
- Venlafaxine Hydrochloride Extended Release 37.5 mg
- Venlafaxine Hydrochloride Extended Release 150 mg
- Venlafaxine Hydrochloride Extended Release 75 mg
- Zolpidem Tartrate Extended Release 12.5 mg
- Zolpidem Tartrate Extended Release 6.25 mg
References
- [1]Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 08/19/2011
- Innovate Us. What is Hypromellose? http://www.innovateus.net/health/what-hypromellose. Accessed 08/19/2011
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.